Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $60.00 |
|---|---|
| Enterprise Value | $-219,057.00 |
| Earnings per Share | $-19.13 |
| Beta | 9.37 |
| Outstanding Shares | 25,873 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -15.81 |
| Debt to Equity | -0.63 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
OncoSec Medical Incorporated was an immuno-oncology firm focused on the advanced stages of drug development. Its primary mission involved devising, perfecting, and bringing to market DNA-based treatments administered directly into tumors...